Federal contract award

N3239825P0607

QTY 2- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (1 PLATE), QTY 3- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (5 PLATE), AND QTY 1- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (25 PLATE) TO BE USED WITH AN MSD MESO QUICKPLEX SQ 120 ANALYZER.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeNAVAL MEDICAL RESEARCH CENTER
NAICS325413 — In-Vitro Diagnostic Substance Manufacturing
PSC6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$72.4K
Current contract value$72.4K
Potential contract value / ceiling$72.4K
Start dateJul 7, 2025
Current end dateSep 30, 2025
Potential end dateSep 30, 2025
Latest award activitySep 10, 2025
Source loadedAug 15, 2026

Funding and modification history

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 10, 2025P00002$0QTY 2- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (1 PLATE), QTY 3- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (5 PLATE), AND QTY 1- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (25 PLATE) TO BE USED WITH AN MSD MESO QUICKPLEX SQ 120 ANALYZER.
Aug 8, 2025P00001$0QTY 2- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (1 PLATE), QTY 3- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (5 PLATE), AND QTY 1- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (25 PLATE) TO BE USED WITH AN MSD MESO QUICKPLEX SQ 120 ANALYZER.
Jul 7, 20250$72.4KQTY 2- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (1 PLATE), QTY 3- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (5 PLATE), AND QTY 1- V-PLEX PROINFLAMMATORY PANEL 2 (RAT) KIT (25 PLATE) TO BE USED WITH AN MSD MESO QUICKPLEX SQ 120 ANALYZER.

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.